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EDITORIAL OPEN
Working in harmony with Nature: highlights from 2014,
and a look to the future
npj Primary Care Respiratory Medicine (2015) 25, 15031;
doi:10.1038/npjpcrm.2015.31; published online 23 April 2015
‘When you carry out your tasks…do so—to the best of your ability—
in harmony with nature.’ Epictetus1
‘In all things of nature there is something of the marvellous.’
Aristotle2
A year has now elapsed since the Primary Care Respiratory
Journal (PCRJ) was re-launched as npj Primary Care Respiratory
Medicine published by Nature Publishing Group (NPG). In so doing
it became the ﬁrst of the Nature Partner Journals, a major open
access publishing initiative from NPG (http://www.nature.com/
content/NPJ/index.html). The publishing agreement established
between NPG and the Primary Care Respiratory Society UK (PCRS-
UK), in conjunction with the International Primary Care Respiratory
Group (IPCRG), was, of course, a landmark for this journal—and in
our editorial in March 2014 we expressed our delight at the
announcement and our belief that the journal would beneﬁt
hugely from being published by a top international academic
publisher.3 And so it has turned out to be. With apologies to both
Epictetus and Aristotle, this last year has provided many
opportunities for working ‘in harmony with Nature’1 and there
really has been ‘something of the marvellous’2 as we have
developed our relationship with the team at NPG… One year on,
we thought it appropriate to review the events of 2014, to expand
on some of the highlights, and to give you a ﬂavour of our plans
for the future.
ONLINE-ONLY AND OPEN ACCESS: DRAMATIC INCREASE IN
WEBSITE VISITS
There were two major changes which emanated from the new
publishing partnership. The ﬁrst was the loss of the issue-based
print version of the journal. All Nature Partner Journals are online-
only, fully open access journals and are hosted on the nature.com
web platform. All npj Primary Care Respiratory Medicine articles are
therefore freely available on our journal website (www.nature.
com/npjpcrm) and as default are published under the CC-BY
Creative Commons licence, which provides the widest possible
opportunities for re-use whilst authors retain copyright. New
content is published as soon as it is ready for publication rather
than waiting to be assigned to an issue.
Though we understand that the loss of the print issue was a
disappointment for some, for PCRS-UK members this gap has now
been ﬁlled by the new society publication ‘Primary Care
Respiratory Update’. However, most of our readers, particularly
international readers, have for years read the journal online. The
increase in trafﬁc to the new journal website over the last
10 months has been quite extraordinary: there has been a 9%
increase in page views and a 14% increase in site visitors
month on month, culminating in 15,441 site visits and 19,483 page
views/month by January of this year. These ﬁgures comfortably
exceed those from previous years (site visits: 8,204/month
in 2013).
AN ARTICLE PROCESSING CHARGE
The second change was the introduction of an Article Processing
Charge (APC), to be paid by authors upon article acceptance—an
integral part of open access publishing. The trend in academic
journal publishing is very much towards open access, with some
research funders (e.g. the Wellcome Trust in the UK) now
mandating publication of research in fully open access journals,
and an increasing number of open access journals for authors to
choose from.
Our APC currently stands at £2,650 ($4,000, 3,300 Euros) for
original research articles, and £1,000 ($1,500, 1,250 Euros) for all
other article types (such as Review articles, Perspectives and Brief
communications)—as is the case for all Nature Partner Journals.
Understandably, authors will ask what they are getting in return
for their APC… One of the main advantages of being hosted on
the nature.com platform is that all authors who publish in
npj Primary Care Respiratory Medicine beneﬁt from maximum
dissemination of content through one of the most prestigious
scientiﬁc web platforms in the world. The dramatic increase in
website visits over the last 10 months means that authors’ work is
getting increased exposure and is being brought to the attention
of a much wider audience than was previously the case; our
readership is expanding all the time and so this is a beneﬁt that
will increase incrementally. Detailed article metrics are available
for every published article, with daily updates on page views and
social media activity (for example, see http://www.nature.com/
articles/npjpcrm20149/metrics). Our marketing team use online
banner adverts across the nature.com platform as well as e-mail
campaigns and social media adverts to highlight authors’ work,
and our ‘Featured article’ is placed prominently at the top of the
website homepage (www.nature.com/npjpcrm).
All of this means that article submission rates have remained
strong and that authors are continuing to send us high quality
manuscripts. We are delighted that this is the case.
OPEN ACCESS PUBLICATION: SEEKING FINANCIAL ASSISTANCE
Despite all the advantages of open access publishing, we fully
understand that payment of an APC can be an obstacle to some.
However, we are adamant that authors should not feel inhibited
about submitting manuscripts to us simply because of the APC,
especially if they consider our journal the ideal setting for their
work. We as Editors, NPG our publisher, the PCRS-UK and the
IPCRG are in complete agreement on this. Information about
research funders and institutions that provide funding for open
access is available from the NPG open access funding page (http://
www.nature.com/authors/open_access/funding.html). In addition,
the journal operates an APC waiver policy for authors from
HINARI countries, and NPG will consider applications for the APC
to be sponsored in instances where authors cannot pay the
full amount for publication (http://www.nature.com/npjpcrm/
open-access).
CORRESPONDENCE
A glance at our Guide for authors (http://www.nature.com/
authorguide/npjpcrm/npjpcrm-gta.pdf) shows that one type of
article does not require payment of an APC: correspondence.
www.nature.com/npjpcrm
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As we stated in our ﬁrst editorial as newly-appointed Editors-in-
Chief in 2011, ‘critical discussion and feedback are the bread-and-
butter of scientiﬁc progress, and we are very keen to see this
encouraged’.4 We reiterate our belief in this sentiment, and
therefore we’re delighted to receive correspondence relating to
any article published in the journal within six weeks of that article
being published. Once accepted for publication, correspondence
will be published free of charge. Of course, the more correspon-
dence submissions we receive, the more selective we will have to
be in what we publish! For now, however, we encourage readers
to put pen to paper (or, more correctly, ﬁnger to keyboard…), and
in so doing you have a reasonably good expectation that your
contribution will be published.
IMPACT FACTOR
However much we might proclaim the advantages of the nature.
com platform in disseminating authors’ work, a journal’s Impact
factor is of crucial importance for authors planning to submit their
work for publication. Our Impact factor jumped to 2.909 this year,
up from 2.191 the year before, meaning that the journal is now
ranked 2/18 in the Primary Health Care category and 21/53 in the
Respiratory System category. Our strategic aim is to increase our
Impact factor to 4 5.0 over the next few years, and so this is
encouraging. However, given that our citable article Impact factor
denominator is only about 60/year, it’s likely that there will be
some to-ing and fro-ing on the journey! We will continue to be
highly selective in choosing only the very best articles for
publication.
PUBLISHING THE BEST: THANKS TO OUR EDITORS AND
REVIEWERS
Choosing the best articles, of course, involves high quality peer
review, and we are proud to hear from various sources that the
journal has developed a reputation for the quality of its peer
review over the years. This is in large part due to our superb
Associate Editors who handle the vast majority of manuscripts, but
it’s also due to our reviewers (who almost invariably provide peer
review of the highest quality) and our Editorial Board members
(who regularly review papers and give of their time and expert
advice frequently). Every quantitative paper undergoes a thor-
ough statistical review by Gopal Netuveli, our Statistical editor. In
addition, our Education section editors Hilary Pinnock and Jaime
Correia de Sousa regularly commission high quality articles which
are particularly relevant to practising clinicians in the primary care
setting; in so doing, we are fulﬁlling the second of the journal’s
two aims (http://www.nature.com/npjpcrm/about/aims).
We thank all of our editors, reviewers and Editorial Board
members for their expertise and support: it’s a team effort, and we
really are extremely grateful. Our tribute to the full list of 2014




In 2014 our median time to ﬁrst decision for original research
articles was 21 days, and for all other article types it was 19 days.
Median time to ﬁnal decision for original research articles was
36 days, and for all other article types it was 23 days. These
handling times are highly competitive, and we’re justiﬁably proud
of them. Occasionally there will be the odd paper where there has
been an unforeseen delay in obtaining expert reviews, but authors
can expect their manuscript to be dealt with scrupulously fairly in
an efﬁcient and timely manner. For those manuscripts which we
feel do not warrant peer review, authors will receive a rejection
decision within a week of submission—which at least gives them
a speedy response and a chance to select another journal for
submission quickly. Our manuscript handling times have improved
year on year, and we are delighted to pay tribute to our excellent
NPG Editorial ofﬁce team for their speed and efﬁciency.
HEALTHY COMPETITION
The increase in our Impact factor this year, our reputation for high
quality peer review and our quick manuscript handling times do
indeed make this journal ‘highly competitive’. But we entirely
agree with the European Respiratory Journal (ERJ) editors5 that
healthy competition amongst leading journals is to be welcomed
since it reﬂects the dynamism in respiratory research. As they
highlighted in their recent editorial, there is indeed a collegiate
spirit in respiratory publishing. The respiratory journal editors
meet twice a year to analyse developments and to discuss the
challenges common to all medical journal editors, and there is
always a mutually supportive atmosphere during these discus-
sions. There have been times over the last 18 years when the
support of our respiratory editor colleagues has been invaluable to
the editors (past and present) of this journal, and for this we are
very grateful indeed.
RESPIRATORY MEDICINE IN PRIMARY CARE: ARTICLE
HIGHLIGHTS IN 2014
npj Primary Care Respiratory Medicine has its feet ﬁrmly in two
camps: respiratory medicine, and primary care. The journal
publishes work from clinicians and academics working within
any sector that impacts on the primary care management of
respiratory and respiratory-related allergic diseases.
It seems invidious to highlight some papers as opposed to
others, but in 2014 there were a number of papers that excelled,
either in terms of website page views, or in terms of the social
media activity and correspondence they generated. In asthma, we
published a case-control study on its association with obesity in
children,6 and one of the largest ever European surveys of
patients’ symptoms and experience of the disease.7 There were
also a number of papers on various aspects of pharmacological
management.8,9
In chronic obstructive pulmonary disease (COPD), we published
comparable papers on epidemiology, management and outcomes
from the UK and Sweden,10,11 a paper on specialist nurse versus
primary care diagnosis of COPD,12 a randomised controlled trial
(RCT) of tiotropium in patients naïve to maintenance treatment,13
an RCT of a cognitive-behavioural manual versus information
leaﬂets in terms of their effect on health status,14 and a paper from
the PLATINO study on the criteria for selecting patients for
spirometry.15 We do publish a number of qualitative papers, and
two in particular focussed on patients’ experience of identifying
and managing COPD exacerbations,16 and coordination of end-of-
life care.17
Outside of asthma and COPD, there were notable papers
on inappropriate prescribing of inhaled corticosteroids for
respiratory tract infections,18 the diagnosis of interstitial lung
disease,19 and the safety of domiciliary intravenous antibiotics in
bronchiectasis.20
A LOOK TO THE FUTURE
There are a number of projects that are coming to fruition over
the next few months. The ﬁrst is the migration of the old PCRJ
archive to the nature.com platform, which was completed last
month. This important development means that readers will have
access on the nature.com platform to all articles published by this
journal since 1997 to the present day.
The second is the development of our online pre-submission
enquiry facility. As soon as this is established, if authors send in an
Editorial
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abstract we will give them a rapid preliminary assessment within
5 working days telling them whether we’re interested in a
submission; authors will then know whether or not it’s worth
formatting their work according to our Guide for authors (http://
www.nature.com/authorguide/npjpcrm/npjpcrm-gta.pdf). In the
meantime, please don’t hesitate to contact the Editorial ofﬁce at
npjpcrm@nature.com.
The third is the development of the journal website (www.
nature.com/npjpcrm). In fact, this is an ongoing project, and the
NPG web development team are constantly looking at ways to
develop the journal website, making it even more attractive
and helping readers navigate and discover relevant content.
There will be increased use of photos and graphics to
accompany each published article, and we may even consider a
photographic competition with a prize for the best photo
submitted by authors...
Fourthly, we are in discussion with NPG and other Nature
editors so that authors will automatically be offered a number of
alternative in-house submission options if their respiratory manu-
script has been rejected by one of the NPG journals. Once these
details have been ﬁnalised, we will let you know.
One of the features of the old PCRJ was that we regularly
published translations of selected articles to aid accessibility for
readers in countries such as Spain, Portugal and Brazil. The IPCRG
and NPG are currently in discussion about this, and the ambition
remains to restart a translation service for selected articles as soon
as possible. Again, we will keep you updated...
Finally, in association with the NPG Press ofﬁce and our
marketing team, we will be developing our online social media
and general media strategy in order to increase the proﬁle of
selected papers even more.
We think this all sounds exciting and we hope you do too. It
certainly bodes well for the future.
WORKING IN HARMONY WITH NATURE
Joe Bennett is the Senior Publishing Manager for the Nature
Partner Journals at NPG, and since we were the ﬁrst of the ‘npj’
journals we’ve had the privilege of working very closely with
him over this last year or more; we are indebted to him for
all his hard work, advice and encouragement. Martin Delahunty is
the Global Head of Partnership Journals for NPG, and we
thank him wholeheartedly for his support. We’ve already thanked
our Editorial ofﬁce team, but we must also thank our Production
team (in particular Sue Bigmore) for their scrupulous attention
to detail, as well as Emma Hedington and the marketing team
for their success in aiding the dissemination of authors’ work and
for spreading the news about npj Primary Care Respiratory
Medicine.
We are also really grateful for the support we’ve received
from the PCRS-UK Trustees (particularly Patrick White) and the
Executive Committee, Anne Smith the PCRS-UK Chief Executive,
and also the IPCRG Board and its Executive Ofﬁcer Sian Williams.
It truly does require a team effort to publish an academic
journal such as this, and we are privileged to be part of it. 2014
was a really exciting year for the journal, with its transformation
into npj Primary Care Respiratory Medicine and a new publishing
partner in NPG. We have every conﬁdence that 2015 will prove to
be equally good. Our ﬁnal thanks, of course, must go to you, all of
our contributors and readers, without whom there would be no
journal...
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